| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9396 |
| Human Intestinal Absorption | HIA+ | 0.9973 |
| Caco-2 Permeability | Caco2+ | 0.8755 |
| P-glycoprotein Substrate | Non-substrate | 0.6935 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9053 |
| Non-inhibitor | 0.9823 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9147 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5571 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7824 |
| CYP450 2D6 Substrate | Non-substrate | 0.9092 |
| CYP450 3A4 Substrate | Non-substrate | 0.7792 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.6324 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8657 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9384 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6338 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9488 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8293 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8583 |
| Non-inhibitor | 0.9197 |
| AMES Toxicity | Non AMES toxic | 0.9136 |
| Carcinogens | Carcinogens | 0.5297 |
| Fish Toxicity | High FHMT | 0.5087 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8974 |
| Honey Bee Toxicity | High HBT | 0.7251 |
| Biodegradation | Ready biodegradable | 0.6906 |
| Acute Oral Toxicity | III | 0.7875 |
| Carcinogenicity (Three-class) | Non-required | 0.6231 |